What are the guidelines for using Co-amoxiclav (amoxicillin/clavulanic acid) in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-amoxiclav (Amoxicillin/Clavulanic Acid) Use in Pregnancy

Co-amoxiclav is safe to use throughout pregnancy for appropriate bacterial infections, with the important exception that it should be avoided in women at risk of preterm delivery due to a documented association with necrotizing enterocolitis in neonates. 1, 2

Safety Classification and Evidence Base

  • Co-amoxiclav is classified as Pregnancy Category B, meaning reproduction studies in animals (rats and mice at doses up to 1,200 mg/kg/day) showed no evidence of fetal harm, though adequate well-controlled studies in pregnant women are lacking 2

  • The amoxicillin component alone carries Category A designation (the highest safety rating), while the combination formulation is Category B1, both indicating extensive human data showing no increased risk of congenital malformations, premature births, stillbirths, spontaneous abortions, or low birth weight 1

  • Multiple professional societies including the American College of Obstetricians and Gynecologists classify amoxicillin-clavulanate as "Compatible" for use throughout all trimesters 1

Clinical Indications During Pregnancy

Co-amoxiclav is recommended for:

  • Urinary tract infections: 500 mg IV/PO every 8 hours for 3-7 days 1

  • Bacterial respiratory tract infections when beta-lactam coverage is appropriate for the suspected pathogen 3, 1

  • Inflammatory bowel disease complications including perianal Crohn's disease and intra-abdominal abscesses from fistulizing disease 1

  • Salmonella gastroenteritis to prevent extraintestinal spread that could lead to placental and amniotic fluid infection 3

Critical Contraindication: Preterm Delivery Risk

Avoid co-amoxiclav in women at risk of preterm delivery or with preterm prelabor rupture of membranes 1, 2

  • A 2001 study reported increased risk of necrotizing enterocolitis in neonates when mothers received amoxicillin-clavulanate prophylactically for preterm prelabor rupture of membranes 2, 4

  • While subsequent studies between 2001-2008 did not confirm this finding and the original study had methodological limitations, the Centers for Disease Control and Prevention recommend considering alternative antibiotics (such as amoxicillin alone) in women with threatened preterm labor 1, 4

  • In women with threatened preterm labor requiring antibiotic coverage, use amoxicillin alone, ampicillin, cefotaxime, or ceftriaxone instead 3

Advantages Over Alternative Antibiotics

Co-amoxiclav is preferred over several other antibiotic classes:

  • Unlike fluoroquinolones, which should be avoided entirely during pregnancy, beta-lactam antibiotics including co-amoxiclav have not been associated with teratogenicity or increased toxicity 3

  • Unlike tetracyclines (including doxycycline), which are contraindicated due to increased hepatotoxicity and staining of fetal teeth and bones, co-amoxiclav has no such risks 3

  • Unlike clarithromycin, which showed increased risk for birth defects in animal studies and increased spontaneous abortion in one human study, co-amoxiclav has superior safety data 3

  • Co-amoxiclav is preferred over azithromycin due to its superior safety classification when both would provide adequate coverage 1

Dosing and Administration

Standard dosing during pregnancy:

  • 500 mg orally every 8 hours for most indications 5, 1

  • 500 mg IV/PO every 8 hours for urinary tract infections 1

  • Duration typically 7-14 days depending on infection type and severity 5

Breastfeeding Compatibility

Co-amoxiclav is compatible with breastfeeding 1, 2

  • Penicillins are excreted in breast milk but only at low concentrations 1, 2

  • The Academy of Breastfeeding Medicine and World Health Organization recommend monitoring breastfed infants for gastrointestinal effects due to potential alteration of intestinal flora, though serious adverse events are rare 1

  • Caution should be exercised as amoxicillin use by nursing mothers may lead to sensitization of infants 2

Important Drug Interactions During Pregnancy

  • Oral contraceptives: Amoxicillin may affect intestinal flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral contraceptives (relevant for postpartum contraception planning) 6

  • Hormonal effects: Following administration of ampicillin to pregnant women, a transient decrease in plasma concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone and estradiol has been noted; this effect may also occur with co-amoxiclav 2

Common Pitfalls to Avoid

  • Do not confuse co-amoxiclav's safety profile with absolutely contraindicated antibiotics: Tetracyclines and fluoroquinolones are contraindicated in pregnancy, while co-amoxiclav is safe except in the specific context of threatened preterm delivery 5, 7

  • Do not use co-amoxiclav for prophylaxis in preterm prelabor rupture of membranes; use amoxicillin alone, ampicillin, or cephalosporins instead 3, 1

  • Do not assume all beta-lactams are interchangeable: While amoxicillin alone is Category A, the combination with clavulanic acid is Category B due to the specific concern in preterm delivery scenarios 1, 2

References

Guideline

Augmentin Safety in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Amoxicillin-clavulanic acid in late pregnancy].

Gynecologie, obstetrique, fertilite & senologie, 2022

Guideline

Safety of Amoxicillin During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin Safety During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.